United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News Inside the Pete Pharma–FABRX deal: Can 3D printing finally scale in compounding pharmacies? Pete Pharma partners with FABRX to bring 3D printing to U.S. compounding pharmacies—find out how this could transform personalized medication delivery. byPallavi MadhirajuSeptember 13, 2025